Fierce Pharma
JANUARY 12, 2023
JPM23: Viatris lays out plans to become ophthalmology leader and pull down $1B in eye care sales. zbecker. Thu, 01/12/2023 - 13:07.
MedCity News
JANUARY 12, 2023
UC Davis Health announced the first startup to come out of its health tech innovation incubator. The company, named WellCent, is a platform that allows patients and caregivers to onboard medical devices into their home and access digital health resources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JANUARY 12, 2023
Direct Relief’s Donations of Emergency Use Authorization Covid-19 Medical Products Reach Over 19 Million Worldwide jpiatt Thu, 01/12/2023 - 15:19
MedCity News
JANUARY 12, 2023
California’s Office of the Attorney General contends that drugmakers and pharmacy benefit managers work together to “aggressively raise the list price of insulin in lockstep with each other to artificial levels.” Insulin manufacturers deny the allegations, pointing to availability of lower-cost versions of their products.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
JANUARY 12, 2023
Fierce Pharma Asia—Eisai's Leqembi nod; 2 Astellas licensing deals; Samsung's ADC plan. aliu. Fri, 01/13/2023 - 00:30.
pharmaphorum
JANUARY 12, 2023
Bayer has signed an agreement with Google aimed at using high-level processing power to handle quantum chemistry calculations used to predict the chemical and physical properties of drug molecules at the atomic scale. The deal with the tech giant’s Google Cloud unit revolves around its tensor processing units (TPUs), artificial intelligence-powered accelerators designed to run machine learning models and computationally-intensive workloads that can be customised to specific applications.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Legacy MEDSearch
JANUARY 12, 2023
Medcura, Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, announces that the U.S. Food and Drug Administration (FDA) has granted the coveted Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat. LifeGel is the first and only hemostatic agent to receive Breakthrough Device Designation seeking a new and highly differentiated indication: in surgical procedures (except in ophthalmic and urological) as an adjunctive he
MedCity News
JANUARY 12, 2023
Xofluza, a flu antiviral drug developed by Roche and Shionogi, is now approved in Europe for children age 1 and older. The European Commission decision expands the patient population for the drug, which was previously approved for treating adolescents and adults.
European Pharmaceutical Review
JANUARY 12, 2023
The Sustainable Market Initiative’s (SMI) 2022 Terra Carta Seal , which recognises global companies who are driving innovation and leadership within their industry, has been awarded to pharmaceutical companies GlaxoSmithKline PLC, Sanofi, and Samsung Biologics. Launched in January 2021, Terra Carta is a sustainability recovery plan for Nature, People and Planet.
MedCity News
JANUARY 12, 2023
Microsoft is making a strategic investment in Paige, which is leveraging AI for cancer diagnostics and treatment. Paige will also use Microsoft Azure as its cloud provider for the Paige Platform.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Healthcare Success
JANUARY 12, 2023
It’s easy to find detailed guides on how to respond to reviews. However, most aren’t written specifically for healthcare, meaning they don’t consider HIPAA or other compliance issues. Responding to patient reviews can be tricky. According to HIPAA, hospitals and doctors aren't allowed to share any protected health information (PHI) about reviewers—including whether they're patients.
MedCity News
JANUARY 12, 2023
Dr. B began as a virtual service providing access to Covid-19 vaccines and later Covid-19 treatments. It has now expanded to treatments for dermatology, sexual health, reproductive health and primary care.
pharmaphorum
JANUARY 12, 2023
As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Ben Hargreaves speaks to an expert in the area to learn how drug diversion occurs, and how it can be countered. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market. The problem is growing as abuse of prescription treatments, such as opioids, stimulants, and sedatives also increases , making the diversion of such
PharmaVoice
JANUARY 12, 2023
Merck, Bristol Myers Squibb and others are taking small R&D steps in space that could lead to giant leaps for patients.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Pathway
JANUARY 12, 2023
Micro Labs-Walk-In Interviews for Production / Packaging On 14th Jan’ 2023. Job Description. Hiring for our OSD Manufacturing Facility-Verna, Goa. Departments: Production / Packaging. Qualification: B. Pharma/ M.Pharm. Designation: Officer/ Sr. Officer/ Jr. Officer/ Asst. Officer. Experience: 01 to 05 years. Location: Goa. Date: 14th Jan’ 2023.
pharmaphorum
JANUARY 12, 2023
Verily’s new chief executive Stephen Gillett has lost little time in making his mark on the company, announcing a cull of 15% of its workforce and a new strategy just over a week after taking the helm. The life sciences unit of Google parent Alphabet – which raised $1 billion back in September to fund its precision health agenda and business development activities, including possible acquisitions – said the move would allow it to streamline its operations.
Pharma Pathway
JANUARY 12, 2023
SunGlow Lifescience Pvt. Ltd-Openings for Production/ QC/ RA/ QMS/ ARD/ FRD/ Boiler Operator Dept. -Apply Now. Job Description. SunGlow Lifescience Pvt. Ltd was incorporated in January 2010 and was founded by a group of experienced industry professionals. Our Corporate office is located in Chennai, Indian. The first facility located in Puducherry, a small state in the southern part of Indian, about 145 kilometres south of Chennai manufacturing for the domestic market.
Modus
JANUARY 12, 2023
Everyone is selling something these days. Professional athletes, TikTok influencers, and even your local Girl Scout troop ? are all offering something to prospective buyers—and each is looking for a way to improve their efforts. But while some may focus on an advertising stunt, or a clever approach, the key to successful sales is understanding the importance of relationships.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharma Pathway
JANUARY 12, 2023
BIOCON – Walk-In Drive for Freshers in Engineering / Maintenance Assistants On 15th Jan’ 2023. Job Description. Walk-In Drive for Freshers in Engineering / Maintenance Assistants On 15th Jan’ 2023 @ BIOCON. Role: Engineering / Maintenance Assistants. Qualification: Diploma/ Graduates in Mechanical/ Electrical/ Instrumentation Stream. Date: 15th Jan’ 2023.
PharmaTimes
JANUARY 12, 2023
Agreement ensures that clients can access Novotech's early to late-phase CRO services across Europe
pharmaphorum
JANUARY 12, 2023
Oramed Pharma has conceded defeat in its attempt to bring an oral formulation of insulin to market for people with type 2 diabetes, after its ORMD-0801 candidate missed the mark in a phase 3 trial. The announcement marks the disappointing end of a marathon effort by Oramed to develop an oral insulin formulation for type 2 diabetes struggling to control blood sugar on standard therapies and as an alternative to injections.
Eversana Intouch
JANUARY 12, 2023
Each year, we forecast several trends that will influence life-sciences marketing the most in the months to come ahead. Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. You can read our complete whitepaper — today, let’s talk about one of those pressing issues today: talent.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Pharma Pathway
JANUARY 12, 2023
Chemveda Life Sciences Pvt. Ltd- Walk-In Interviews for Discovery Chemistry Solutions On 13th Jan’ 2022. Job Description. Walk-In Interviews for Discovery Chemistry Solutions On 13th Jan’ 2022 @ Chemveda Life Sciences Pvt. Ltd. •We are Currently hiring for research associates, senior research & associate Scientists with 2+ years of relevant experience.
Pharma Marketing Network
JANUARY 12, 2023
Kite’s Christi Shaw, AbbVie’s Jag Dosanjh, and LexisNexis® Risk Solution’s Liz Paulson Earn Top Industry Honors. FAIRFIELD, NJ (12 January, 2023) – The Healthcare Businesswomen’s Association (HBA) announces the 2023 Woman of the Year, Honorable Mentor, and STAR. Recognized for their outstanding contributions to healthcare and the advancement of women in the workplace, the honorees will be celebrated at HBA’s 33rd annual Woman of the Year event on 16 May in New York City and virtually around the
Pharma Pathway
JANUARY 12, 2023
Kwality Pharmaceuticals Ltd- Openings for Freshers in QA/ Warehouse/ Engineering Dept. -Apply Now. Job Description. Openings for Freshers in QA/ Warehouse/ Engineering Dept. -Apply Now @ Kwality Pharmaceuticals Ltd. Departments: QA/ Warehouse/ Engineering. Role: Trainee. Qualification: B.Pharm/ D.Pharm/ B.Sc/ BA/ Any Graduate/ ITI. Experience: Freshers.
Pharmaceutical Technology
JANUARY 12, 2023
The US Food and Drug Administration (FDA) has approved AstraZeneca and Avillion’s Airsupra (albuterol/budesonide), to treat asthma. Previously known as PT027, Airsupra is a pressurised metered-dose inhaler (pMDI), fixed-dose combination rescue medication. It comprises short-acting beta2-agonist (SABA) albuterol and anti-inflammatory inhaled corticosteroid (ICS) budesonide.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
pharmaphorum
JANUARY 12, 2023
Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class, pressurised metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol, a short-acting beta2-agonist (SABA), and budesonide (an anti-inflammatory inhaled corticosteroid or ICS) – Airsupra is the first and only rescue medication approved in the US for as-needed use to reduce
Pharmaceutical Technology
JANUARY 12, 2023
Solid Biosciences has entered a strategic research collaboration with Phlox Therapeutics to expedite the development of new therapies for rare cardiac diseases. Under the research partnership deal, the companies will develop new precision genetic medicines for a severe form of genetic dilated cardiomyopathy (DCM). The collaboration will use the vector biology, manufacturing capabilities and the drug development experience of Solid Biosciences and Phlox Therapeutics’ knowledge in genetic cardiomy
pharmaphorum
JANUARY 12, 2023
The Attorney General of Alabama has threatened to use an obscure law passed in 2006 to prosecute women who terminate a pregnancy using pharmacological means, shortly after the FDA made access to the drugs easier. Steve Marshall said this week that the state would use a law prohibiting ‘chemical endangerment’ of a child – introduced in 2006 to protect children from exposure to illicit drugs – as the basis for prosecutions.
Pharmaceutical Technology
JANUARY 12, 2023
The National Medical Products Administration (NMPA) of China has approved Takeda ’s Exkivity (mobocertinib) to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) in adult patients. The oral tyrosine kinase inhibitor (TKI) Exkivity has been specifically designed for targeting epidermal growth factor receptor (EGFR) Exon20 insertion mutations selectively.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
264 
Let's personalize your content